Symmetry Medical, Inc. (SMA) Misses Q4 EPS by 3c; Guides FY12 adj.-EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailGet Alerts SMA Hot Sheet
Join SI Premium – FREE
Symmetry Medical, Inc. (NYSE: SMA) reported Q4 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $84.5 million versus the consensus estimate of $80.8 million.
Symmetry Medical, Inc. sees FY2012 EPS of $0.55-$0.65, versus the consensus of $0.56.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Symmetry Medical, Inc. sees FY2012 EPS of $0.55-$0.65, versus the consensus of $0.56.
For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle sets $225B revenue target for fiscal year 2030
- Wex, Inc. (WEX) Tops Q3 EPS by 48c; offers guidance
- Cactus, Inc. (WHD) Tops Q3 EPS by 19c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
